NVIDIA Expands BioNeMo Platform to Enhance AI-Driven Drug Discovery
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5h ago
0mins
Source: seekingalpha
- AI Lab Collaboration: NVIDIA's partnership with Eli Lilly to launch an AI co-innovation lab aims to leverage large-scale computing and AI models to accelerate drug discovery, which is expected to significantly enhance R&D efficiency and reduce time to market.
- Automated Lab Infrastructure: Collaborating with Thermo Fisher Scientific, NVIDIA is embedding AI into scientific instruments to build autonomous laboratory infrastructure, thereby reducing reliance on human intervention in high-throughput research labs and enhancing automation in experiment design and execution.
- New BioNeMo Components: NVIDIA introduced new components to BioNeMo, including open models for RNA structure prediction and drug synthesis feasibility, along with GPU-accelerated cheminformatics tools, aimed at providing standardized workflows for training and deploying biological foundation models, driving innovation in the biotech sector.
- Adoption Trends: A growing number of biotech firms, AI drug developers, and lab automation companies are adopting the BioNeMo platform to connect digital AI systems with physical laboratories, allowing experimental data to continuously feed back into model development, thus advancing scientific research.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVDA is 255.63 USD with a low forecast of 185.00 USD and a high forecast of 352.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
40 Analyst Rating
38 Buy
1 Hold
1 Sell
Strong Buy
Current: 184.860
Low
185.00
Averages
255.63
High
352.00
Current: 184.860
Low
185.00
Averages
255.63
High
352.00
About NVDA
NVIDIA Corporation is a full-stack computing infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. The Company’s segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing platforms and artificial intelligence (AI) solutions and software; networking; automotive platforms and autonomous and electric vehicle solutions; Jetson for robotics and other embedded platforms, and DGX Cloud computing services. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating industrial AI and digital twin applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
